Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

View source ↗

Summary

An investigational study is evaluating the efficacy of QbMobile for treatment monitoring in individuals with ADHD and is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QbMobile

Snippet

Sponsor: Qbtech AB | Conditions: Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder (ADD) | Status: ENROLLING_BY_INVITATION